Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 83 | 101 | 183 | 2 | 123 |
| Gross Profit | 83 | 101 | 183 | 2 | 123 |
| Operating Expenses | 6,780 | 5,713 | 5,408 | 6,057 | 6,726 |
| Operating Income | -6,696 | -5,612 | -5,225 | -6,055 | -6,603 |
| Interest Expense | -130 | 176 | -190 | -733 | 680 |
| Other Income | -109 | 184 | -97 | 1,878 | 2,200 |
| Pre-tax Income | -6,676 | -5,604 | -5,132 | -3,443 | -5,083 |
| Net Income Continuous | -6,676 | -5,604 | -4,728 | -3,443 | -5,083 |
| Net Income Discontinuous | -124 | 110 | 1,844 | 20,495 | 208 |
| Minority Interests | N/A | N/A | 505 | 261 | -226 |
| Net Income | $-6,799 | $-5,494 | $-3,388 | $16,791 | $-4,649 |
| EPS Basic Total Ops | -2.19 | -1.77 | -1.07 | 5.36 | -1.49 |
| EPS Basic Continuous Ops | -2.15 | -1.81 | -1.52 | -1.11 | -1.64 |
| EPS Basic Discontinuous Ops | -0.04 | 0.04 | 0.59 | 6.60 | 0.07 |
| EPS Diluted Total Ops | -2.19 | -1.77 | -1.07 | 5.36 | -1.49 |
| EPS Diluted Continuous Ops | -2.15 | -1.81 | -1.52 | -1.11 | -1.64 |
| EPS Diluted Discontinuous Ops | -0.04 | 0.04 | 0.59 | 6.60 | 0.07 |
| EPS Diluted Before Non-Recurring Items | -2.15 | -1.81 | -1.70 | -1.10 | -1.60 |
| EBITDA(a) | $-6,522 | $-5,427 | $-5,005 | $-5,854 | $-6,389 |